Healthcare -
Biotechnology - NASDAQ - US
$ 10.27
-2.38 %
$ 433 M
Market Cap
-3.4
P/E
URGN - STOCK-BASED COMPENSATION
Stock-based Compensation URGN - UroGen Pharma Ltd.
9.34 M
LAST VALUE
-36.42%
2 YEAR CAGR
-21.14%
5 YEAR CAGR
32.96%
10 YEAR CAGR